Search

  • HOME
  • Search
Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
Chung-Feng Huang, Ming-Lung Yu
Clin Mol Hepatol. 2019;25(2):168-171.   Published online February 11, 2019
View: 4806   Download: 177  Citations: 4
Original Article
Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection
Shinya Sato, Kei Moriya, Masanori Furukawa, Soichiro Saikawa, Tadashi Namisaki, Mitsuteru Kitade, Hideto Kawaratani, Kosuke Kaji, Hiroaki Takaya, Naotaka Shimozato, Yasuhiko Sawada, Kenichiro Seki, Koh Kitagawa, Takemi Akahane, Akira Mitoro, Yasushi Okura, Junichi Yamao, Hitoshi Yoshiji
Clin Mol Hepatol. 2019;25(1):65-73.   Published online February 25, 2019
View: 6655   Download: 131  Citations: 3
Review
Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals
Soon Young Ko, Won Hyeok Choe
Clin Mol Hepatol. 2018;24(4):351-357.   Published online March 16, 2018
View: 8178   Download: 339  Citation: 1
Editorial
Use of sofosbuvir in chronic kidney disease: Is it necessary?
Tae Seop Lim, Sang Hoon Ahn
Clin Mol Hepatol. 2017;23(4):308-310.   Published online September 26, 2017
View: 4808   Download: 117  Citations: 6
Original Article
Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea
Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
Clin Mol Hepatol. 2015;21(4):358-364.   Published online December 24, 2015
View: 7240   Download: 102  Citations: 10
Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea
Suh Yoon Yang, Hyun Woong Lee, Youn Jae Lee, Sung Jae Park, Ki Young Yoo, Hyung Joon Kim
Clin Mol Hepatol. 2015;21(2):125-130.   Published online June 26, 2015
View: 7941   Download: 56  Citations: 4
No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients
Nae-Yun Heo, Young-Suk Lim, Woochang Lee, Minkyung Oh, Jiyun An, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Han Chu Lee, Yung Sang Lee, Dong Jin Suh
Clin Mol Hepatol. 2014;20(2):177-184.   Published online June 30, 2014
View: 5785   Download: 48  Citations: 4
The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients
Hee Jae Jung, Young Seok Kim, Sang Gyune Kim, Yun Nah Lee, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Boo Sung Kim
Clin Mol Hepatol. 2014;20(1):38-46.   Published online March 26, 2014
View: 7506   Download: 77  Citations: 31
Efficacy of peginterferon and ribavirin is associated with the IL28B gene in Korean patients with chronic hepatitis C
Seok Hoo Jeong, Young Kul Jung, Jae Won Yang, Sang Jin Park, Jong Woo Kim, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim
Clin Mol Hepatol. 2012;18(4):360-367.   Published online December 21, 2012
View: 6163   Download: 30  Citations: 12
A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C
Byung Chul You, Young Seok Kim, Hun il Kim, Se Hun Kim, Seung Sik Park, Yu Ri Seo, Sang Gyune Kim, Se Whan Lee, Hong Soo Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim
Clin Mol Hepatol. 2012;18(3):272-278.   Published online September 25, 2012
View: 6278   Download: 35  Citation: 1
Editorial
Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients
Woo Jin Chung
Clin Mol Hepatol. 2012;18(3):268-271.   Published online September 25, 2012
View: 4812   Download: 43  Citation: 1
Original Article
Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin
Sang Bun Choi, Youn Jae Lee, Jae Ik Lee, Young Jin Song, Byoung Jin Choi, Jong Han Kim, Eun Uk Jung, Sung Jae Park, Sang Heon Lee, Ji Hyun Kim, Jung Sik Choi, Sam Ryong Jee, Sang Yong Seol
Clin Mol Hepatol. 2011;17(3):183-188.   Published online September 30, 2011
View: 5733   Download: 32  Citations: 3
Case Report
Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C
Jae Hee Lim, Yun Nah Lee, Young Seok Kim, Sang Gyune Kim, Seung Won Jeong, Jae Young Jang, Hong Soo Kim, Sae Hwan Lee, Tae Kwann Park
Clin Mol Hepatol. 2011;17(1):61-65.   Published online March 21, 2011
View: 7016   Download: 46  Citations: 11
Review
New treatments for chronic hepatitis C
Jae Young Jang, Raymond T. Chung
Clin Mol Hepatol. 2010;16(3):263-277.   Published online September 30, 2010
View: 6686   Download: 42  Citations: 14
3
Clinical efficacy and safety of the combination therapy of peginterferon alpha and ribavirin in cirrhotic patients with HCV infection
Hong Ryeol Cheong, M.D., Hyun Young Woo, M.D., Jeong Heo, M.D., Ki Tae Yoon, M.D., Dong Uk Kim, M.D., Gwang Ha Kim, M.D., Dae Hwan Kang, M.D., Geun Am Song, M.D., Mong Cho, M.D.
Clin Mol Hepatol. 2010;16(1):38-48.   Published online March 26, 2010
View: 4737   Download: 20  Citations: 9
Current status of Liver diseases in Korea: Hepatitis C
Young Suk Lim
Clin Mol Hepatol. 2009;15(60):25-28.   Published online December 31, 2009
View: 5441   Download: 27  Citations: 18
A comparison of 24- vs. 48-week peginterferon plus ribavirin in patients with genotype 1 chronic hepatitis C
Mi Na Kim, M.D. Ki Tae Yoon, M.D. Jun Yong Park, M.D. Do Young Kim, M.D. Sang Hoon Ahn, M.D. Chae Yoon Chon, M.D. Kwang-Hyub Han, M.D.
Clin Mol Hepatol. 2009;15(4):496-503.   Published online December 31, 2009
View: 4127   Download: 17  Citations: 2
4
A case of sudden-onset hearing Loss in a patient treated with peginterferon α-2b and ribavirin for chronic hepatitis C
Min Ki Shin , Tae Hyo Kim , Kang Ju , Chang Yoon Ha , Hyun Ju Min , Woon Tae Jung , Ok Jae Lee
Clin Mol Hepatol. 2009;15(3):370-374.   Published online September 30, 2009
View: 4052   Download: 25  Citations: 3
A Case of Bell`s Palsy Associated with Peginterferon Alfa-2a and Ribavirin Therapy for Chronic Hepatitis C Virus Infection
Moo Yeol Lee, M.D., Hoon Cho, M.D., Yeong Muk Kim, M.D., and Joon Sang Lee, M.D.
Clin Mol Hepatol. 2006;12(3):444-448.   Published online January 1, 2000
View: 2309   Download: 17
3
Efficacy of Combination of Interferon α 2a , Ribavirin and UDCA in the Treatment of Chronic Hepatitis C
Dong Jin Suh , Neung Hwa Park , Young Hwa Chung , Young Sang Lee
Clin Mol Hepatol. 1998;4(2):109-119.
View: 2084   Download: 14
1 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1529
TOTAL : 1142968
Close layer